SMARCA1 and colorectal cancer: It has been elucidated that the chromatin accessibility alters followed by phenotypic abnormality once the deficient expression of SWI/SNF components occurs, e.g., ARID1A in HCT116 colorectal cancer cells and injury-induced liver-progenitor-like cells [46, 47].